Rallybio Holdings LLC (RLYB)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 299k | 299k |
営業利益 | -17.31M | -18.94M | -20.3M | -20.01M | -21.73M | -20.47M | -17.52M | -12.7M |
税引前収入 | -16.2M | -17.32M | -18.63M | -18.37M | -20.24M | -19.03M | -16.24M | -11.47M |
純利益 | -16.2M | -17.32M | -18.63M | -18.37M | -20.24M | -19.03M | -16.24M | -11.47M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -17.27M | -18.86M | -20.24M | -19.92M | -21.69M | -20.31M | -17.38M | -12.45M |
EBITDA | -17.27M | -18.9M | -20.26M | -19.97M | -21.69M | -20.44M | -17.49M | -12.67M |
年末 2023年12月31日 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -17.75M | -26.83M | -47.15M | -68.96M | -80.97M |
税引前収入 | -17.56M | -26.46M | -47.01M | -66.65M | -74.56M |
純利益 | -17.56M | -26.45M | -47.01M | -66.65M | -74.56M |
優先配当 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -3.081 | -4.64 | -1.463 | -1.762 | -1.973 |
EBIT | -17.58M | -26.58M | -47.06M | -68.62M | -80.71M |
EBITDA | -17.72M | -26.76M | -47.04M | -68.79M | -80.82M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約